Author

Jiayan Sun

Observed names: JIA-YAN SUN, Jia-Yan Sun

Institutions: Soochow University, The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital)

Observed institutions: Shanghai Jiao Tong University, Ruijin Hospital, Soochow University, The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital)

OpenAlex ID: A5109166344

PCSK9 inhibitor alleviates experimental pulmonary fibrosis-induced pulmonary hypertension via attenuating epithelial-mesenchymal transition by suppressing Wnt/β-catenin signaling in vivo and in vitro

2024 · Jiancheng Lin, Zetao Pan, et al. · Frontiers in Medicine · 7

PCSK9 inhibition alleviates sepsis-induced myocardial dysfunction by facilitating PINK1/parkin-associated mitophagy

2026 · Jiancheng Lin, Zetao Pan, et al. · Frontiers in Pharmacology

SIX1 mediates pulmonary arterial hypertension endothelial dysfunction through the IL-6/STAT3 axis

2026 · Hou-Mei Xiang, Yi Wang, et al. · Journal of Thoracic Disease

Androgen receptor inhibitor ameliorates pulmonary arterial hypertension by enhancing the apoptosis level through suppressing the Notch3/Hes5 pathway

2025 · Jiayan Sun, Jiancheng Lin, et al. · Frontiers in Pharmacology

Association of interferon regulator factor 1 upregulation with pulmonary arterial hypertension

2025 · Yuheng Ye, Min Zhou, et al. · Journal of Thoracic Disease

Noninvasive arterial stiffness indices and cardiovascular risk in hypertensive patients

2009 · JUN-LI ZUO, SHAO-LI CHU, et al. · International Journal of Cardiology

Works count: 6

Citation count: 7

H-index: 1

I10-index: